Password-based electronic signatures are widely used in manufacturing software (MES, ERP) in the pharmaceutical industry, putting at risk data integrity and regulatory compliance. The solution is the biometric electronic signature.

The ALCOA+ requirements defined by the FDA establish, among others, the characteristics for correct identification of employees in regulated pharmaceutical processes. The use of biometrics solves the current difficulties in meeting them.

Current employee identification methods in pharmaceutical manufacturing processes cause data integrity breaches in GMP regulated environments, which can be solved with biometrics.